slides · global inventory
Resolution
Beat collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 42,534
Current window 30,421-30,450
Pages 1,418
Rows per page 30
Beat
30,421-30,450 of 42,534
15
The slide uses a bulleted list to present key safety outcomes, including lack of serious adverse events and specific laboratory findings.Arbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
16
Arbutus Biopharma | Investor Presentation Deck | 28 slidesArbutus Biopharma | Investor Presentation Deck | 28 slides · Arbutus Biopharma
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
06
The slide uses a hub-and-spoke visual arrangement with a central image of a patient.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
07
The slide uses a central circular image overlaying four surrounding text boxes containing key performance indicators.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
08
The slide uses a circular, iterative process diagram to suggest continuous growth.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
09
The slide uses a 3D-like coordinate system to show expansion vectors.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
10
The slide uses a map to visualize global reach, supplemented by two tables detailing approval dates for two different products.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · WhatLoop · Cost Of Inaction1 hit
23
Clinical trial design schematic showing 2:1 randomization between Efgartigimod and Placebo over 24 weeks.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
24
The slide uses a process flow diagram to illustrate the clinical trial structure.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
25
The slide outlines a multi-phase trial structure with specific cohorts (IMNM, ASyS, DM) and a GO/NO-GO decision point.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
26
The slide uses a timeline-based process diagram to illustrate the clinical trial structure.argenx SE | Investor Presentation Deck | 26 slides · argenx
Conference presentation Investor relations Beat · Resolution1 hit
11
Includes footnotes regarding non-GAAP reconciliation and prior year depreciation.Azek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
12
Azek | Results Presentation Deck | 15 slidesAzek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
13
Standard financial disclosure slide for non-GAAP metrics.Azek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
14
Includes detailed footnotes explaining adjustments for stock-based compensation, acquisition costs, and other non-recurring items.Azek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
15
This is a closing slide for an investor presentation.Azek | Results Presentation Deck | 15 slides · The AZEK Company
Conference presentation Investor relations Beat · Action1 hit
17
Blue Apron | Investor Presentation Deck | 23 slidesBlue Apron | Investor Presentation Deck | 23 slides · Blue Apron
Pitch deck Investor relations Beat · Financials1 hit
16
Blue Apron | Results Presentation Deck | 24 slidesBlue Apron | Results Presentation Deck | 24 slides · Blue Apron
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
17
Blue Apron | Results Presentation Deck | 24 slidesBlue Apron | Results Presentation Deck | 24 slides · Blue Apron
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
06
Uses a before-after-bridge framework to contrast current pain points with the proposed solution.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
The slide uses a two-column layout to contrast the hardware platform with the consumable cartridges.Bluejay | Investor Presentation Deck | 20 slides · Bluejay Diagnostics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
17
The slide uses a process flow diagram to illustrate the trial structure.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
18
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
19
The slide details specific event counts and target hazard ratios for OS and PFS endpoints.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
20
The chart shows a dose-response curve where longer incubation times (48+ hours) result in higher efficacy (lower cell viability) at lower concentrations compared to 24 hours.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
21
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
22
The slide uses a medical illustration of the brain to map patient counts and positivity rates to specific anatomical regions.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
23
Chimerix | Investor Presentation Deck | 43 slidesChimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
24
Slide 24 of the deck.Chimerix | Investor Presentation Deck | 43 slides · Chimerix
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit